Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Merrill Lynch & Co. | IPB | Aug 30, 2024 | 27.18 | +3.54 |
Mersana Therapeutics | MRSN | Aug 30, 2024 | 1.58 | +3.95 |
Merus N.V | MRUS | Aug 30, 2024 | 50.99 | +1.01 |
Mesa Air Group | MESA | Aug 30, 2024 | 1.23 | -2.77 |
Mesa Laboratories | MLAB | Aug 30, 2024 | 133.69 | -0.38 |
Mesa Royalty Trust | MTR | Aug 30, 2024 | 6.34 | -2.31 |
Mesabi Royalty Trust | MSB | Aug 30, 2024 | 16.97 | -0.35 |
Mesoblast ADR | MESO | Aug 30, 2024 | 6.74 | +4.17 |
Meta Data ADR | AIU | Aug 30, 2024 | 0.61 | 0.00 |
Meta Materials | MMAT | Aug 30, 2024 | 0.64 | 0.00 |
Meta Platforms A | META | Aug 30, 2024 | 521.31 | +0.60 |
Metagenomi | MGX | Aug 30, 2024 | 2.97 | -0.34 |
Metal Sky Star Acquisition | MSSA | Aug 30, 2024 | 11.31 | -0.18 |
Metalla Royalty & Streaming | MTA | Aug 30, 2024 | 2.99 | +1.01 |
Metallus | MTUS | Aug 30, 2024 | 16.26 | -0.91 |
Metals Acquisition | MTAL | Aug 30, 2024 | 11.23 | -2.60 |
Methalpa Technology Holding | MATH | Aug 30, 2024 | 1.12 | -1.75 |
Methanex | MEOH | Aug 30, 2024 | 46.69 | +0.97 |
Methode Electronics | MEI | Aug 30, 2024 | 10.42 | -0.10 |
MetLife | MET | Aug 30, 2024 | 77.48 | +0.98 |
Metlife Pref A | MET-A | Aug 30, 2024 | 24.06 | -3.18 |
Metlife Pref E | MET-E | Aug 30, 2024 | 24.66 | -2.07 |
Metlife Pref F | MET-F | Aug 30, 2024 | 21.71 | -2.12 |
MetroCity Bankshares | MCBS | Aug 30, 2024 | 30.65 | +0.16 |
Metropolitan Bank | MCB | Aug 30, 2024 | 51.71 | -0.54 |
Mettler-Toledo International | MTD | Aug 30, 2024 | 1 439.08 | +0.55 |
Mexco Energy | MXC | Aug 30, 2024 | 11.78 | -0.93 |
Mexico Equity And Income Fund | MXE | Aug 30, 2024 | 8.86 | +0.24 |
Mexico Fund | MXF | Aug 30, 2024 | 14.85 | +0.54 |
Mexico Investable Mkt Idx MSCI Ishares | EWW | Aug 30, 2024 | 53.04 | +0.38 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.